The Asia Pacific Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Asia Pacific Examiner.

Press releases published on August 26, 2026

NOMAD Power Solutions, Inc. Receives DOE Authorization to Advance Vermont Long-Duration Energy Storage Project into Phase 3
Gulf Resources Announces International Expansion Plan and Strategic Cooperation Agreement with a Brazilian company, Montes Verdes Participacoes Ltda.
Ultra-High-Grade Drilling Materially Expands Monte Alto
Mint Accelerates Robotics Expansion with Yunji Technology for Strategic Development of Next Generation Commercial Grade Service Robot
Russia's Fuel Crunch Raises Harvest and Inflation Risks for Kazakhstan, Teniz Capital Says
Computer Monitor Market Poised for Sustained Expansion with 5.67% CAGR Until 2035
Helical Fusion Publishes Peer-Reviewed Paper on HTS Magnet Technology Validated Through Collaboration with NIFS
CURRENC Capital and Securitize Announce Strategic Collaboration to Advance Issuer-Sponsored Tokenization of Public Equities
Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent
MIMARU Expands in Osaka as American Guest Stays Rise 46%
Greenland Mines Announces Pricing of $20 Million Public Offering
Odyssey Therapeutics to Participate in Upcoming Investor Conferences
SONORO GOLD COMPLETES ACQUISITION OF 23 MINERAL CONCESSIONS TO FURTHER EXPAND THE CERRO CALICHE GOLD PROJECT
Cre8 Enterprise Limited Reports Record Number of Customers Served for the First Half of 2026
BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM
MicrobiotiX Completes Sentinel Cohort of its First-in-human Clinical Trial of MP101 for Pneumonia
GTCFX Ended the Tour at ProFX Africa 2026 Successfully and Received 3 Prestigious Honors
Super Hi Reports Unaudited Financial Results for the Second Quarter of 2026
Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors
Ligand to Participate in September Investor Conferences

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Asia Pacific Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.